Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resum

Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resum

Item
http://www.wikidata.org/entity/Q37304799
Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapyImpact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study.Biomarkers and HIV-associated cardiovascular disease.T-cell activation, both pre- and post-HAART levels, correlates with carotid artery stiffness over 6.5 years among HIV-infected women in the WIHSA prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapyCardiovascular implications from untreated human immunodeficiency virus infection.Increased inflammation but similar physical composition and function in older-aged, HIV-1 infected subjects.HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.Increased CD34+/KDR+ cells are not associated with carotid artery intima-media thickness progression in chronic HIV-positive subjects.Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation.Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression.HIV-specific immune dysregulation and atherosclerosis.Risk of coronary heart disease in patients with HIV infection.
P2860

Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resum

Item
http://www.wikidata.org/entity/Q37304799
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Increased soluble vascular cel ...... ecule-1 levels following resum
@en
Increased soluble vascular cel ...... ecule-1 levels following resum
@nl
type
label
Increased soluble vascular cel ...... ecule-1 levels following resum
@en
Increased soluble vascular cel ...... ecule-1 levels following resum
@nl
prefLabel
Increased soluble vascular cel ...... ecule-1 levels following resum
@en
Increased soluble vascular cel ...... ecule-1 levels following resum
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Increased soluble vascular cel ...... ecule-1 levels following resum
@en
P2093
P2860
P304
P31
P356
10.1097/QAD.0B013E328303BE2A
P407
P433
P478
P577
P698
P921
P932